GE HealthCare Technologies Inc. (NASDAQ:GEHC) Shares Bought by Prudential PLC

Prudential PLC grew its holdings in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 0.9% in the 4th quarter, Holdings Channel reports. The fund owned 20,022 shares of the company’s stock after acquiring an additional 174 shares during the period. Prudential PLC’s holdings in GE HealthCare Technologies were worth $1,548,000 as of its most recent SEC filing.

Other large investors also recently modified their holdings of the company. Fortitude Family Office LLC acquired a new position in GE HealthCare Technologies in the fourth quarter worth about $29,000. Turtle Creek Wealth Advisors LLC acquired a new position in GE HealthCare Technologies in the fourth quarter worth about $30,000. Sachetta LLC acquired a new position in GE HealthCare Technologies in the fourth quarter worth about $31,000. Central Bank & Trust Co. acquired a new position in GE HealthCare Technologies in the fourth quarter worth about $33,000. Finally, Valued Wealth Advisors LLC acquired a new position in GE HealthCare Technologies in the fourth quarter worth about $33,000. 82.06% of the stock is currently owned by institutional investors and hedge funds.

GE HealthCare Technologies Stock Performance

GEHC opened at $76.34 on Monday. GE HealthCare Technologies Inc. has a twelve month low of $62.35 and a twelve month high of $94.50. The stock has a market cap of $34.85 billion, a PE ratio of 22.32, a price-to-earnings-growth ratio of 2.75 and a beta of 1.22. The business’s 50 day moving average is $82.63 and its 200-day moving average is $81.05. The company has a current ratio of 1.06, a quick ratio of 0.83 and a debt-to-equity ratio of 1.11.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its earnings results on Tuesday, April 30th. The company reported $0.90 EPS for the quarter, hitting the consensus estimate of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm had revenue of $4.65 billion for the quarter, compared to analysts’ expectations of $4.80 billion. During the same quarter in the previous year, the company earned $0.85 earnings per share. The firm’s quarterly revenue was down 1.2% compared to the same quarter last year. On average, analysts predict that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current year.

GE HealthCare Technologies Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were issued a dividend of $0.03 per share. The ex-dividend date of this dividend was Thursday, April 18th. This represents a $0.12 annualized dividend and a yield of 0.16%. GE HealthCare Technologies’s payout ratio is 3.51%.

Insider Buying and Selling

In other news, insider Frank R. Jimenez bought 1,315 shares of the company’s stock in a transaction that occurred on Wednesday, May 1st. The shares were purchased at an average price of $76.52 per share, with a total value of $100,623.80. Following the completion of the acquisition, the insider now directly owns 75,796 shares in the company, valued at $5,799,909.92. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In other news, insider Frank R. Jimenez acquired 1,315 shares of the stock in a transaction on Wednesday, May 1st. The shares were purchased at an average cost of $76.52 per share, for a total transaction of $100,623.80. Following the transaction, the insider now owns 75,796 shares in the company, valued at approximately $5,799,909.92. The acquisition was disclosed in a filing with the SEC, which is available through the SEC website. Also, CTO Taha Kass-Hout sold 3,300 shares of GE HealthCare Technologies stock in a transaction that occurred on Tuesday, May 28th. The stock was sold at an average price of $78.70, for a total transaction of $259,710.00. Following the transaction, the chief technology officer now owns 67,300 shares in the company, valued at $5,296,510. The disclosure for this sale can be found here. Insiders have sold a total of 90,482 shares of company stock valued at $7,369,137 over the last quarter. Corporate insiders own 0.27% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms recently commented on GEHC. UBS Group upgraded GE HealthCare Technologies from a “sell” rating to a “neutral” rating and lifted their price target for the stock from $66.00 to $88.00 in a research note on Monday, February 12th. The Goldman Sachs Group began coverage on GE HealthCare Technologies in a research note on Thursday, May 30th. They issued a “neutral” rating and a $87.00 target price for the company. Argus lifted their target price on GE HealthCare Technologies from $80.00 to $110.00 and gave the company a “buy” rating in a research note on Monday, April 1st. Mizuho decreased their target price on GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating for the company in a research note on Wednesday, May 1st. Finally, Citigroup lifted their target price on GE HealthCare Technologies from $88.00 to $103.00 and gave the company a “buy” rating in a research note on Wednesday, April 3rd. Five research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $94.09.

GE HealthCare Technologies Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.